Paloma Partners Management CO Heron Therapeutics, Inc. Transaction History

Paloma Partners Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$17.42 - $26.61 $195,609 - $298,803	-11,229 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.36 - $21.39 $183,706 - $240,188	11,229 New	11,229 $208,000
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $235,332 - $367,747	-12,769 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $188,981 - $240,695	12,769	12,769 $231,000

193

129M

94.7K

148K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $227M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.